Content about Aventis

August 5, 2010

The Food and Drug Administration has approved a new formulation of a chemotherapy drug made...

August 2, 2010

French drug maker Sanofi-Aventis has made an offer for Genzyme, according to published reports....

July 22, 2010

The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

 

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

 

 

July 7, 2010

A big-ticket acquisition could be in the works for French drug maker Sanofi-Aventis, according to...

June 30, 2010

Sanofi-Aventis and the Juvenile Diabetes Research Foundation announced they jointly will develop therapeutic treatments for...

June 29, 2010

A biotechnology company will be acquired by one of the world's largest drug makers....

May 16, 2010

As of Feb. 9, Sanofi-Aventis officially entered the self-care solution arena with its acquisition of...

March 30, 2010

French drug maker Sanofi-Aventis and U.S.-based AgaMatrix will develop blood-glucose monitoring devices that use an...

March 10, 2010

A leading global pharmaceutical company has completed its acquisition of a consumer healthcare products manufacturer....

February 11, 2010

Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...

WHAT IT MEANS AND WHY ITS IMPORTANT Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as CVS and Walgreens, as blockbuster drugs like Pfizer’s Lipitor (atorvastatin) and Sanofi-Aventis’ and Bristol-Myers Squibb’s Plavix (clopidogrel bisulfate) come off patent and face generic competition, but they would do well to remember an important factor: the patent cliff.

February 10, 2010

Pfizer, Merck & Co. and Roche have made big mega-acquisitions. Eli Lilly has pumped money...

February 8, 2010

A leading global pharmaceutical company has successfully completed its tender offer for all outstanding shares...

January 25, 2010

Sanofi-Aventis has cleared its tender offer for Chattem with government antitrust officials, the French drug...

January 11, 2010

The Food and Drug Administration has approved a flu vaccine from Sanofi Pasteur for use...

January 10, 2010

Sanofi-Aventis is the latest pharma powerhouse to make the move toward over-the-counter medicine with its...

January 10, 2010

Sanofi-Aventis on Monday announced the commencement of a tender offer through its wholly-owned subsidiary, River...

December 20, 2009

This is further substantiation that the business of over-the-counter medicines, particularly those sold in the...

NEW YORK This is further substantiation that the business of over-the-counter medicines, particularly those sold in the U.S. market, is a key growth driver for pharma companies. If you weren’t convinced when Pfizer re-entered the OTC market with its acquisition of Wyeth, then you certainly should be convinced now.

 

December 10, 2009

PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another...

NEW YORK PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another indication that the field could become the next generation of community pharmacy.

February 12, 2008

French beauty company L’Oreal Paris announced on Wednesday that in 2007 group profit rose 29 percent....

September 19, 2007

Teva is introducing its generic to the Sanofi-Aventis anti-fungal medication Penlac nail lacquer....